---
figid: PMC4359241__oncotarget-06-592-g002
figlink: /pmc/articles/PMC4359241/figure/F2/
number: Figure 2
caption: 'Testosterone circulates in the blood and is bound to albumin, whereas free
  testosterone is introduced into prostate cells and is subsequently converted to
  DHT by 5-alpha-reductase. Binding of DHT to the AR induces dissociation from HSPs
  and receptor phosphorylation. The AR dimerizes and can bind to androgen-response
  elements in the promoter regions of target genes, leading to growth, survival and
  production of PSA. Enzalutamide, formerly called MDV3100, exerts its mechanism of
  action during several steps in the AR signaling pathway including inhibition of
  AR binding to androgens, inhibition of nuclear translocation of AR, inhibition of
  AR association to DNA, and AR amplification. As some of those aberrations may occur
  late in the disease, it is unknown at this point if enzalutamide will have a role
  upfront in the management of prostate cancer. Abbreviations: AR, androgen receptor;
  DHT, dihydrotestosterone; GTA, general transcription activation; HSP, heat-shock
  protein; SHBG, sex-hormone-binding globulin; AKT, akt serine/threonine kinase; DHEA,
  dihydroepiandrosterone; ERK, extracellular signal-regulated kinase; P, phosphorylated
  residues; PI3K, phosphoinositide 3-kinase; PTEN, phoshatase and tensin homolog.'
pmcid: PMC4359241
papertitle: 'Androgen receptors beyond prostate cancer: an old marker as a new target.'
reftext: Javier Munoz, et al. Oncotarget. 2015 Jan;6(2):592-603.
pmc_ranked_result_index: '19932'
pathway_score: 0.9549406
filename: oncotarget-06-592-g002.jpg
figtitle: 'Androgen receptors beyond prostate cancer: an old marker as a new target'
year: '2015'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4359241__oncotarget-06-592-g002.html
  '@type': Dataset
  description: 'Testosterone circulates in the blood and is bound to albumin, whereas
    free testosterone is introduced into prostate cells and is subsequently converted
    to DHT by 5-alpha-reductase. Binding of DHT to the AR induces dissociation from
    HSPs and receptor phosphorylation. The AR dimerizes and can bind to androgen-response
    elements in the promoter regions of target genes, leading to growth, survival
    and production of PSA. Enzalutamide, formerly called MDV3100, exerts its mechanism
    of action during several steps in the AR signaling pathway including inhibition
    of AR binding to androgens, inhibition of nuclear translocation of AR, inhibition
    of AR association to DNA, and AR amplification. As some of those aberrations may
    occur late in the disease, it is unknown at this point if enzalutamide will have
    a role upfront in the management of prostate cancer. Abbreviations: AR, androgen
    receptor; DHT, dihydrotestosterone; GTA, general transcription activation; HSP,
    heat-shock protein; SHBG, sex-hormone-binding globulin; AKT, akt serine/threonine
    kinase; DHEA, dihydroepiandrosterone; ERK, extracellular signal-regulated kinase;
    P, phosphorylated residues; PI3K, phosphoinositide 3-kinase; PTEN, phoshatase
    and tensin homolog.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TYK2
  - CYP2C9
  - PIK3CB
  - CYP3A4
  - AR
  - SLTM
  - MAP2K1
  - HRAS
  - KRAS
  - NRAS
  - STAT3
  - CYP17A1
  - CYP1A2
  - LHB
  - GNRH1
  - AKT1
  - AKT2
  - JAK3
  - AKT3
  - PIK3R4
  - PIK3CA
  - MAP2K2
  - POMC
  - PIK3R5
  - MAPK3
  - JAK1
  - PIK3R6
  - CGA
  - BMPR2
  - PIK3CG
  - JAK2
  - MAPK1
  - PIK3CD
  - PIK3R3
  - Androgen
  - Androgens
  - Cholesterol
  - Testosterone
  - Tyrosine
  - Finasteride
  - Cancer
genes:
- word: JAK/STAT3
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: TYK2
  entrez: '7297'
- word: CYP2C9
  symbol: CYP2C9
  source: hgnc_symbol
  hgnc_symbol: CYP2C9
  entrez: '1559'
- word: PI3K/AKT
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: CYP3A4
  symbol: CYP3A4
  source: hgnc_symbol
  hgnc_symbol: CYP3A4
  entrez: '1576'
- word: AR
  symbol: AR
  source: hgnc_symbol
  hgnc_symbol: AR
  entrez: '367'
- word: Mets
  symbol: Met
  source: hgnc_alias_symbol
  hgnc_symbol: SLTM
  entrez: '79811'
- word: RAS/MEK/ERK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: RAS/MEK/ERK
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: RAS/MEK/ERK
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: RAS/MEK/ERK
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: JAK/STAT3
  symbol: STAT3
  source: hgnc_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: CYP17
  symbol: CYP17
  source: hgnc_prev_symbol
  hgnc_symbol: CYP17A1
  entrez: '1586'
- word: CYP1A2
  symbol: CYP1A2
  source: hgnc_symbol
  hgnc_symbol: CYP1A2
  entrez: '1544'
- word: LH
  symbol: LH
  source: bioentities_symbol
  hgnc_symbol: LHB
  entrez: '3972'
- word: LHRH
  symbol: LHRH
  source: hgnc_prev_symbol
  hgnc_symbol: GNRH1
  entrez: '2796'
- word: PI3K/AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: PI3K/AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: JAK/STAT3
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK3
  entrez: '3718'
- word: PI3K/AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: PI3K/AKT
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K/AKT
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: RAS/MEK/ERK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: ACTH
  symbol: ACTH
  source: hgnc_alias_symbol
  hgnc_symbol: POMC
  entrez: '5443'
- word: PI3K/AKT
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: RAS/MEK/ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: JAK/STAT3
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK1
  entrez: '3716'
- word: PI3K/AKT
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: LH
  symbol: LH
  source: bioentities_symbol
  hgnc_symbol: CGA
  entrez: '1081'
- word: Talk
  symbol: T-ALK
  source: hgnc_alias_symbol
  hgnc_symbol: BMPR2
  entrez: '659'
- word: PI3K/AKT
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: JAK/STAT3
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: RAS/MEK/ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: PI3K/AKT
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K/AKT
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
chemicals:
- word: Androgen
  source: MESH
  identifier: D000728
- word: Androgens
  source: MESH
  identifier: D000728
- word: Cholesterol
  source: MESH
  identifier: D002784
- word: Testosterone
  source: MESH
  identifier: D013739
- word: Tyrosine
  source: MESH
  identifier: D014443
- word: Finasteride
  source: MESH
  identifier: D018120
diseases:
- word: Cancer
  source: ''
  identifier: ''
---
